Hard to Treat Diseases Inc. (HTDS)
Manufactures vaccines and biopharmaceutical drugs for treating diseases in China and globally
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
HTDS is trading near its 52-week high and above both its 50- and 200-day moving averages, showing positive near-term momentum. Analyst coverage appears thin or unavailable for this micro-cap stock. The current data reflects strength in the price trend, though investors should note the extremely low share price and limited liquidity typical of stocks in this range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—